| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.28 | 3e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.26 | 2e-06 |